Hostname: page-component-5c6d5d7d68-vt8vv Total loading time: 0.001 Render date: 2024-08-20T10:15:20.087Z Has data issue: false hasContentIssue false
  • English
  • Français

Catatonia and not neuroleptic malignant syndrome

Published online by Cambridge University Press:  02 January 2018

Conrad Melton Swartz
Conrad Melton Swartz*
Affiliation:
Department of Psychiatric Medicine, East Carolina University, Greenville, North Carolina, USA
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 162 , Issue 2 , February 1993 , pp. 274 - 275
Copyright
Copyright © Royal College of Psychiatrists, 1993 

References

Greenfield, D., Conrad, C., Kincare, P., et al (1987) Treatment of catatonia with low-dose lorazepam. American Journal of Psychiatry, 144, 1224–1225.Google Scholar
Pope, H. G., Keck, P. E. Jr. & McElroy, S. L. (1986) Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. American Journal of Psychiatry, 143, 1227–1233.Google Scholar
Shalev, A., Hermesh, H. & Munitz, H. (1989) Mortality from neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 50, 18–25.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.